Forestier F, Salvanet-Bouccara A
J Fr Ophtalmol. 1984;7(5):385-91.
The literature concerning different kinds of draining implants used since the beginning of this century to increase the reliability of filtering operations to relieve glaucoma has been reviewed. The Krupin-Denver valve implant, which allows a filtration surgery with a pressure sensitive, unidirectional valve implant function drew the author's attention. This device consists in an open supramid tube sealed to a silastic tube ending with a slit valve which opens under a 11 to 14 mmHg intra ocular pressure. The supramid tube is inserted 1 to 4 mm long into the anterior chamber from the corneoscleral limbus, and the silastic tube is set under a scleral flap. Personal results are exposed from february 1981 to december 1983, 15 eyes have been treated (5 neovascular glaucomas, 5 glaucomas in aphakia, 4 congenital glaucomas and one chronic glaucoma). After mean follow up time of 13 months (1 to 34 months), the Krupin valve insertion controls the intraocular pressure in 14 eyes, without antiglaucoma medication in 5, and 7 cases are controlled with an additional local therapy, and further 2 cases with a general treatment. In the discussion, the improvements brought by this valve implant are studied facing the three great reasons of failure in the filtering operations as defined in 1980 by Molteno and Cairns: immediate post surgical hypotony, blockage of the internal end of the draining fistula, blockage of the external end of the draining fistula.
回顾了自本世纪初以来使用的各种引流植入物的文献,这些植入物旨在提高滤过手术缓解青光眼的可靠性。Krupin-Denver瓣膜植入物引起了作者的关注,它具有压力敏感的单向瓣膜植入功能,可进行滤过手术。该装置由一根开放的聚酰胺管组成,该管密封在一根硅橡胶管上,硅橡胶管末端有一个裂隙瓣膜,在眼内压为11至14 mmHg时打开。聚酰胺管从角膜缘插入前房1至4毫米长,硅橡胶管置于巩膜瓣下。展示了1981年2月至1983年12月的个人结果,共治疗了15只眼(5例新生血管性青光眼、5例无晶状体性青光眼、4例先天性青光眼和1例慢性青光眼)。平均随访时间为13个月(1至34个月)后,Krupin瓣膜植入术控制了14只眼的眼压,5只眼无需抗青光眼药物治疗,7例通过额外的局部治疗得到控制,另外2例通过全身治疗得到控制。在讨论中,针对Molteno和Cairns在1980年定义的滤过手术失败的三大原因,研究了这种瓣膜植入物带来的改进:术后立即低眼压、引流瘘管内端阻塞、引流瘘管外端阻塞。